HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk
Abstract Diabetes increases the risk of Cardio-vascular disease (CVD). CVD is more prevalent in type 2 diabetes (T2D) than type 1 diabetes (T1D), but the mortality risk is higher in T1D than in T2D. The pathophysiology of CVD in T1D is poorly defined. To learn more about biological pathways that are...
Guardado en:
Autores principales: | Sanket Kumar Shukla, Weijing Liu, Kunal Sikder, Sankar Addya, Amrita Sarkar, Yidong Wei, Khadija Rafiq |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d7916d403ad485ea2d773875879bd51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of key enzymes involved in triacylglycerol biosynthesis in mycobacteria
por: Agostina Crotta Asis, et al.
Publicado: (2021) -
The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides
por: Gillian M. Fisher, et al.
Publicado: (2020) -
The Ketogenic Diet: Safety, Morbidity, and Mortality
por: Taufiqurrachman Nasihun
Publicado: (2019) -
The Ketogenic Effect of Medium-Chain Triacylglycerides
por: Ting-Yu Lin, et al.
Publicado: (2021) -
Neuroprotection by the Ketogenic Diet: Evidence and Controversies
por: Sarah M. Gough, et al.
Publicado: (2021)